- Home
- GIW vs ANGO Comparison
GIW vs ANGO Comparison
Compare GIW & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIW
- ANGO
- Stock Information
- Founded
- GIW 2025
- ANGO 1988
- Country
- GIW United States
- ANGO United States
- Employees
- GIW N/A
- ANGO N/A
- Industry
- GIW
- ANGO Medical/Dental Instruments
- Sector
- GIW
- ANGO Health Care
- Exchange
- GIW Nasdaq
- ANGO Nasdaq
- Market Cap
- GIW 361.6M
- ANGO 400.8M
- IPO Year
- GIW 2025
- ANGO 2004
- Fundamental
- Price
- GIW $9.90
- ANGO $11.94
- Analyst Decision
- GIW
- ANGO Strong Buy
- Analyst Count
- GIW 0
- ANGO 3
- Target Price
- GIW N/A
- ANGO $19.33
- AVG Volume (30 Days)
- GIW 20.6K
- ANGO 432.5K
- Earning Date
- GIW 01-01-0001
- ANGO 01-07-2026
- Dividend Yield
- GIW N/A
- ANGO N/A
- EPS Growth
- GIW N/A
- ANGO N/A
- EPS
- GIW N/A
- ANGO N/A
- Revenue
- GIW N/A
- ANGO $300,718,000.00
- Revenue This Year
- GIW N/A
- ANGO $8.18
- Revenue Next Year
- GIW N/A
- ANGO $5.15
- P/E Ratio
- GIW N/A
- ANGO N/A
- Revenue Growth
- GIW N/A
- ANGO 2.73
- 52 Week Low
- GIW $10.01
- ANGO $6.71
- 52 Week High
- GIW $10.39
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- GIW N/A
- ANGO 51.03
- Support Level
- GIW N/A
- ANGO $11.67
- Resistance Level
- GIW N/A
- ANGO $12.09
- Average True Range (ATR)
- GIW 0.00
- ANGO 0.45
- MACD
- GIW 0.00
- ANGO -0.10
- Stochastic Oscillator
- GIW 0.00
- ANGO 38.98
About GIW GigCapital8 Corp. Class A Ordinary Shares
GigCapital8 Corp is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.